期刊文献+

高效液相色谱法测定质粒pUDKH中曲拉通X-100的含量 被引量:4

Quantitative analysis of Triton X-100 in plasmid pUDKH by high performance liquid chromatography
下载PDF
导出
摘要 目的检测质粒pUDKH最终产品中去污剂曲拉通X 10 0 (TritonX 10 0 )的残留含量。方法用高效液相色谱法测定TritonX 10 0残留含量 ,色谱柱为C18柱 ,流动相为乙腈 水 (70∶30 ) ,流速为 1.0ml/min ,进样量 10 μl,检测波长 2 2 3nm。结果平均回收率为 10 0 .19% ,日内精密度为 4 .36 % ,日间精密度为 4 .17% ,TritonX 10 0在 1.2 5~2 0 μg/ml浓度范围内呈线性关系。pUDKH产品中的TritonX 10 0含量在 2 .2 7~ 3.0 0 μg/ml之间。TritonX 10 0的最低检测限可达 1.0 μg/ml。 结论此法有良好的准确度与精密度 ,供试品不需预处理 ,不受其它成分的干扰。 PurposeIn the process of plasmid pUDKH production, Triton X-100 was used as a virus inactivated solvent. The residual Triton X-100 concentration must be determined in final products.MethodsA high performance liquid chromatography was used. The system included a Hypersil silica column, eluted with acetonitrile -H 2O(70∶30). The flow rate was 1.0 ml/min. ResultsThe detection limit was low (1.0 μg/ml) with detection at 223nm. The calibration linear range was between 1.25 μg/ml and 20 μg/ml.ConclusionThe method was rapid. It did not need sample pretreatment. The residual Triton X-100 in our final pUDKH products was determined at 2.27~3.00 μg/ml level.
出处 《中国生化药物杂志》 CAS CSCD 2004年第4期210-211,共2页 Chinese Journal of Biochemical Pharmaceutics
基金 国家"8 63"课题 ( 2 0 0 1AA2 170 61)
关键词 质粒pUDKH 曲拉通X—100 高效液相色谱 含量测定 plasmid pUDKH Triton X-100 high performance liquid chromatography quantitation
  • 相关文献

参考文献5

  • 1哈小琴,任建平,毕建进,张津辉,张庆林,吴祖泽.人肝细胞生长因子基因治疗犬肢体动脉闭塞病[J].科学通报,2003,48(6):571-574. 被引量:9
  • 2张庆林,毕建进,高春蕾,齐子荣,郭树华,哈小琴,宋京,龚萍,王小娜,吴祖泽.质粒pcDNA3-HGF的大规模纯化制备研究[J].生物技术通讯,2000,11(4):268-270. 被引量:9
  • 3Josic D, Schulz P, Biesert L, et al. Issues in the development of medical products based on human plasma [J] . J Chromatogr B ,1997,694:253-269.
  • 4Kamiusuki T, Monde T, Nemoto F, et al. Separation and characterization of octylphenol ethoxylate surfactants used by reversed-phase high-performance liquid chromatography on branched fluorinated silica gel columns[J]. J Chromatogr A, 1999,852:475-485.
  • 5karlsson G, Hinz AC, Henriksson E , et al. Determination of Triton X-100 in plasma-derived coagulation factor Ⅷ and factor Ⅸ products by reversed-phase high-performance liquid chromatography[J]. J Chromatogr A ,2002,946:163-168.

二级参考文献27

  • 1[1]Tyrrell M R, Wolfe J H. Critical leg ischemia: an appraisal of clinical definitions. Joint vascular research group. Br J Surg, 1993, 80: 177~180
  • 2[2]Eneroth M, Persson B M. Amputation for occlusive arterial disease. A prospective multicentre study of 177 amputees. Int Orthop, 1992, 16: 383~387
  • 3[3]Dawson I, Keller B P, Brand R, et al. Late outcomes of limb loss after failed infrainguinal bypass. J Vasc Surg, 1995, 21: 613~622
  • 4[4]Uematsu Y, Fujise N, Kohsaka K, et al. Effective administration route for the deleted form of hepatocyte growth factor to exert its pharmacological effects. J Pharm Sci, 1999, 88(1): 131~135
  • 5[5]Taniyama Y, Morishita R, Aoki M, et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia model: preclinical study for treatment of peripheral arterial disease. Gene Ther, 2001, 8: 181~189
  • 6[6]Isner J M, Walsh K, Symes J, et al. Arterial gene transfer for therapeutic angiogenesis in patient with peripheral artery disease. Hum Gene Ther, 1996, 7: 959~988
  • 7[7]Nakamura J, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature, 1989, 342: 440~443
  • 8[8]Bhargava M, Joseph A, Knesel J, et al. Scatter factor and hepatocyte growth factor: activities, properties, and mechanism. Cell Growth Differ, 1992, 3: 11~20
  • 9[9]Hayashi S, Morishita R, Nakamura S, et al. Potential role of hepatocyte growth factor, a novel angiogenic growth factor in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells. Circulation, 1999, 9(100): Ⅱ301~308
  • 10[10]Nakamura Y, Morishita R, Nakamura S, et al. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertention, 1996, 28: 409~413

共引文献14

同被引文献19

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部